Clay Collins joined Crown CFO in 2017, bringing over 20 years of finance and accounting experience. His background includes the pharmaceutical, media and healthcare industries. Clay uses a thoughtful, hands-on approach to financial systems and analysis to provide meaningful tools for business leaders.
Before joining Crown CFO, Clay was Director of Finance with BriovaRx Infusion Services, part of OptumRx/UnitedHealth Group. He was involved in the successful growth and execution of several private equity backed transactions, leading up to his most recent role, where he guided the finance transition of Axelacare Health Solutions to the ownership of OptumRx.
Clay earned his degree in Accounting from the University of Kansas.
